Showing results (161-170 of 194) with videos related to

Sort By:
Pageof 20
The Lancet Regional Health. Europe|January 19, 2026
Eculizumab withdrawal and monitoring in atypical haemolytic uraemic syndrome (SETS aHUS): a multicentre, open label, prospective, single arm trialAndrew Bryant, Jan Lecouturier, Giovany Orozco-Leal, et al.
Frontiers in Immunology|December 27, 2021
Homodimeric Minimal Factor H: In Vivo Tracking and Extended Dosing Studies in Factor H Deficient MiceOla Kamala, Talat H Malik, Thomas M Hallam, et al.
Nature Genetics|September 17, 2013
Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degenerationJohanna M Seddon, Yi Yu, Elizabeth C Miller, et al.
HRB Open Research|April 15, 2021
The future of genomics in Ireland - focus on genomics for healthCathal Seoighe, Adrian P Bracken, Patrick Buckley, et al.
Lancet (London, England)|September 28, 2025
Oral iptacopan therapy in patients with C3 glomerulopathy: a randomised, double-blind, parallel group, multicentre, placebo-controlled, phase 3 studyDavid Kavanagh, Andrew S Bomback, Marina Vivarelli, et al.
Journal of the American Society of Nephrology : JASN|October 23, 2015
A De Novo Deletion in the Regulators of Complement Activation Cluster Producing a Hybrid Complement Factor H/Complement Factor H-Related 3 Gene in Atypical Hemolytic Uremic SyndromeRachel C Challis, Geisilaine S R Araujo, Edwin K S Wong, et al.
Pageof 20